Research Article
A small sample study of the STEPP approach to assessing treatment–covariate interactions in survival data
Abstract
A new, intuitive method has recently been proposed to explore treatment–covariate interactions in survival data arising from two treatment arms of a clinical trial. The method is based on constructing overlapping subpopulations of patients with respect to one (or more) covariates of interest and in observing the pattern of the treatment effects estimated across the subpopulations. A plot of these treatment effects is called a subpopulation treatment effect pattern plot. Here, we explore the small sample characteristics of the asymptotic results associated with the method and develop an alternative permutation distribution‐based approach to inference that should be preferred for smaller sample sizes. We then describe an extension of the method to the case in which the pattern of estimated quantiles of survivor functions is of interest. Copyright © 2009 John Wiley & Sons, Ltd.
Citing Literature
Number of times cited according to CrossRef: 28
- Yanghui Liu, Riquan Zhang, Shujie Ma, Xiuzhen Zhang, Personalized treatment selection via the covariate-specific treatment effect curve for longitudinal data, Statistical Theory and Related Fields, 10.1080/24754269.2020.1762059, (1-12), (2020).
- Richard S. Finn, Massimo Cristofanilli, Johannes Ettl, Karen A. Gelmon, Marco Colleoni, Carla Giorgetti, Eric Gauthier, Yuan Liu, Dongrui R. Lu, Zhe Zhang, Cynthia Huang Bartlett, Dennis J. Slamon, Nicholas C. Turner, Hope S. Rugo, Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials, Breast Cancer Research and Treatment, 10.1007/s10549-020-05782-4, (2020).
- Bernhard Haller, Kurt Ulm, Alexander Hapfelmeier, A Simulation Study Comparing Different Statistical Approaches for the Identification of Predictive Biomarkers, Computational and Mathematical Methods in Medicine, 10.1155/2019/7037230, 2019, (1-15), (2019).
- G. Mi, W. Li, T. S. Nguyen, Characterize and Dichotomize a Continuous Biomarker, Statistical Methods in Biomarker and Early Clinical Development, 10.1007/978-3-030-31503-0, (23-38), (2019).
- H. S. Rugo, R. S. Finn, V. Diéras, J. Ettl, O. Lipatov, A. A. Joy, N. Harbeck, A. Castrellon, S. Iyer, D. R. Lu, A. Mori, E. R. Gauthier, C. Huang Bartlett, K. A. Gelmon, D. J. Slamon, Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up, Breast Cancer Research and Treatment, 10.1007/s10549-018-05125-4, (2019).
- Dan Li, Chenhan Zhong, Xiujun Tang, Linzhen Yu, Kefeng Ding, Ying Yuan, Competing nomograms help in the selection of elderly patients with colon cancer for adjuvant chemotherapy, Journal of Cancer Research and Clinical Oncology, 10.1007/s00432-018-2611-y, 144, 5, (909-923), (2018).
- Angelo Di Leo, Joyce O’Shaughnessy, George W. Sledge, Miguel Martin, Yong Lin, Martin Frenzel, Molly C. Hardebeck, Ian C. Smith, Antonio Llombart-Cussac, Matthew P. Goetz, Stephen Johnston, Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy, npj Breast Cancer, 10.1038/s41523-018-0094-2, 4, 1, (2018).
- Bernhard Haller, Hans-Henning Eckstein, Peter A. Ringleb, Kurt Ulm, Investigation of age–treatment interaction in the SPACE trial using different statistical approaches, Journal of Applied Statistics, 10.1080/02664763.2018.1558186, (1-13), (2018).
- Wai-Ki Yip, Subgroup Analyses and Information from Clinical Trials on Breast Cancer, Breast Cancer, 10.1007/978-3-319-48848-6, (891-903), (2017).
- Yunbei Ma, Xiao-Hua Zhou, Treatment selection in a randomized clinical trial via covariate-specific treatment effect curves, Statistical Methods in Medical Research, 10.1177/0962280214541724, 26, 1, (124-141), (2016).
- Xin Victoria Wang, Bernard Cole, Marco Bonetti, Richard D. Gelber, Meta‐STEPP: subpopulation treatment effect pattern plot for individual patient data meta‐analysis, Statistics in Medicine, 10.1002/sim.6958, 35, 21, (3704-3716), (2016).
- Massimo Cristofanilli, Nicholas C Turner, Igor Bondarenko, Jungsil Ro, Seock-Ah Im, Norikazu Masuda, Marco Colleoni, Angela DeMichele, Sherene Loi, Sunil Verma, Hiroji Iwata, Nadia Harbeck, Ke Zhang, Kathy Puyana Theall, Yuqiu Jiang, Cynthia Huang Bartlett, Maria Koehler, Dennis Slamon, Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial, The Lancet Oncology, 10.1016/S1470-2045(15)00613-0, 17, 4, (425-439), (2016).
- Wai-Ki Yip, Marco Bonetti, Bernard F Cole, William Barcella, Xin Victoria Wang, Ann Lazar, Richard D Gelber, Subpopulation Treatment Effect Pattern Plot (STEPP) analysis for continuous, binary, and count outcomes, Clinical Trials: Journal of the Society for Clinical Trials, 10.1177/1740774516643297, 13, 4, (382-390), (2016).
- Xuan-zhang Huang, Peng Gao, Yong-xi Song, Jing-xu Sun, Xiao-wan Chen, Jun-hua Zhao, Bin Ma, Jun Wang, Zhen-ning Wang, Impact of age on efficacy of postoperative oxaliplatin-based chemotherapy in patients with rectal cancer after neoadjuvant chemoradiotherapy, Oncotarget, 10.18632/oncotarget.7544, 7, 15, (19643-19653), (2016).
- Patrizia Vici, Laura Pizzuti, Isabella Sperduti, Antonio Frassoldati, Clara Natoli, Teresa Gamucci, Silverio Tomao, Andrea Michelotti, Luca Moscetti, Stefania Gori, Editta Baldini, Francesco Giotta, Alessandra Cassano, Daniele Santini, Diana Giannarelli, Luigi Di Lauro, Domenico Cristiano Corsi, Paolo Marchetti, Valentina Sini, Domenico Sergi, Maddalena Barba, Marcello Maugeri-Saccà, Michelangelo Russillo, Lucia Mentuccia, Loretta D'Onofrio, Laura Iezzi, Angelo Fedele Scinto, Lucia Da Ros, Ilaria Bertolini, Maria Luisa Basile, Valentina Rossi, Ruggero De Maria, Filippo Montemurro, “Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome, Oncotarget, 10.18632/oncotarget.7480, 7, 14, (17932-17944), (2016).
- Ann A Lazar, Marco Bonetti, Bernard F Cole, Wai-ki Yip, Richard D Gelber, Identifying treatment effect heterogeneity in clinical trials using subpopulations of events: STEPP, Clinical Trials, 10.1177/1740774515609106, 13, 2, (169-179), (2015).
- Alex Dmitrienko, Christoph Muysers, Arno Fritsch, Ilya Lipkovich, General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trials, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2015.1092033, 26, 1, (71-98), (2015).
- Yicong Liu, Wenyu Jiang, Bingshu E. Chen, Testing for treatment‐biomarker interaction based on local partial‐likelihood, Statistics in Medicine, 10.1002/sim.6563, 34, 27, (3516-3530), (2015).
- Howard M. Mackey, Thomas Bengtsson, Sample size and threshold estimation for clinical trials with predictive biomarkers, Contemporary Clinical Trials, 10.1016/j.cct.2013.09.005, 36, 2, (664-672), (2013).
- S. Zurrida, V. Bagnardi, G. Curigliano, M.G. Mastropasqua, R. Orecchia, D. Disalvatore, M. Greco, L. Cataliotti, G. D’Aiuto, N. Talakhadze, A. Goldhirsch, G. Viale, High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy, European Journal of Cancer, 10.1016/j.ejca.2013.05.007, 49, 15, (3083-3092), (2013).
- Willemien van de Water, Duveken B.Y. Fontein, Johanna G.H. van Nes, John M.S. Bartlett, Elysée T.M. Hille, Hein Putter, Tammy Robson, Gerrit-Jan Liefers, Rudi M.H. Roumen, Caroline Seynaeve, Luc Y. Dirix, Robert Paridaens, Elma Meershoek-Klein Kranenbarg, Johan W.R. Nortier, Cornelis J.H. van de Velde, Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer – A TEAM study analysis, European Journal of Cancer, 10.1016/j.ejca.2012.07.026, 49, 2, (297-304), (2013).
- Ann H. Partridge, Shari Gelber, Martine J. Piccart-Gebhart, Florine Focant, Matthew Scullion, Eileen Holmes, Eric P. Winer, Richard D. Gelber, Effect of Age on Breast Cancer Outcomes in Women With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From a Herceptin Adjuvant Trial, Journal of Clinical Oncology, 10.1200/JCO.2012.44.1956, 31, 21, (2692-2698), (2013).
- Antonio C. Wolff, Ann A. Lazar, Igor Bondarenko, August M. Garin, Stephen Brincat, Louis Chow, Yan Sun, Zora Neskovic-Konstantinovic, Rodrigo C. Guimaraes, Pierre Fumoleau, Arlene Chan, Soulef Hachemi, Andrew Strahs, Maria Cincotta, Anna Berkenblit, Mizue Krygowski, Lih Lisa Kang, Laurence Moore, Daniel F. Hayes, Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer, Journal of Clinical Oncology, 10.1200/JCO.2011.38.3331, 31, 2, (195-202), (2013).
- Robert Pirker, Stephan Störkel, Anja von Heydebreck, Ilhan Celik, Kenneth J O'Byrne, A STEPP too far for FLEX? – Authors' reply, The Lancet Oncology, 10.1016/S1470-2045(12)70057-8, 13, 2, (e51), (2012).
- Silvia Dellapasqua, Vincenzo Bagnardi, Meredith M. Regan, Nicole Rotmensz, Mauro G. Mastropasqua, Giuseppe Viale, Eugenio Maiorano, Karen N. Price, Richard D. Gelber, Monica Castiglione-Gertsch, Aron Goldhirsch, Marco Colleoni, A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer, The Breast, 10.1016/j.breast.2012.06.003, 21, 5, (621-628), (2012).
- Jan Budczies, Frederick Klauschen, Bruno V. Sinn, Balázs Győrffy, Wolfgang D. Schmitt, Silvia Darb-Esfahani, Carsten Denkert, Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization, PLoS ONE, 10.1371/journal.pone.0051862, 7, 12, (e51862), (2012).
- Katrín Á. Gunnarsdóttir, Maj-Britt Jensen, David Zahrieh, Richard D. Gelber, Ann Knoop, Marco Bonetti, Henning Mouridsen, Bent Ejlertsen, CEF is superior to CMF for tumours with TOP2A aberrations: a Subpopulation Treatment Effect Pattern Plot (STEPP) analysis on Danish Breast Cancer Cooperative Group Study 89D, Breast Cancer Research and Treatment, 10.1007/s10549-010-0931-y, 123, 1, (163-169), (2010).
- Ann A. Lazar, Bernard F. Cole, Marco Bonetti, Richard D. Gelber, Evaluation of Treatment-Effect Heterogeneity Using Biomarkers Measured on a Continuous Scale: Subpopulation Treatment Effect Pattern Plot, Journal of Clinical Oncology, 10.1200/JCO.2009.27.9182, 28, 29, (4539-4544), (2010).
